Literature DB >> 15882531

Comparative study on adjuvanticity of compound Chinese herbal medicinal ingredients.

Deyun Wang1, Yuanliang Hu, Junling Sun, Xiangfeng Kong, Baokang Zhang, Jiaguo Liu.   

Abstract

In order to compare the adjuvant activity of compound Chinese herbal medicinal ingredients (cCHMIs) and filtrate best prescription and dose, two initial screened cCHMIs were prepared and mixed with Newcastle disease (ND) vaccine respectively at three doses to vaccinate 17-day-old chickens, taking the non-adjuvant and oil adjuvant vaccines as controls. On day 7, 14, 21, 28, 35 and 42 after vaccination, the dynamic changes of peripheral lymphocyte proliferation and serum antibody titers in the chickens were determined by means of MTT method and hemagglutination inhibition test. The results showed that two cCHMIs could promote peripheral lymphocyte proliferation and enhance serum antibody titer, of which adjuvant activity was similar to and even stronger than oil adjuvant in promoting lymphocyte proliferation at some time points, and there was a certain dose-effect relationship. The best adjuvant activity of cCHMIs 2 in promoting cellular immunity occurred at middle dose, and cCHMIs 1 in enhancing humoral immunity, at high dose. Based on good synergistic effects of their components, two cCHMIs would be expected as new-type immunologic adjuvants to substitute for oil adjuvant.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882531     DOI: 10.1016/j.vaccine.2005.02.011

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Sulfated modification promotes the immunomodulatory bioactivities of Lyciumbarbarum polysaccharides in vitro.

Authors:  Junmin Wang; Beilei Ge; Chunyan Du; Jingli Xue; Yuwei Zhuang; Kun Xue
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  The Modified JiuWei QiangHuo Decoction Alleviated Severe Lung Injury Induced by H1N1 Influenza Virus by Regulating the NF- κ B Pathway in Mice.

Authors:  Lijuan Chen; Xin Yan; Qianlin Yan; Jiajun Fan; Hai Huang; Xunlong Shi; Lei Han; Tianxiong Han; Haiyan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-18       Impact factor: 2.629

3.  Astragalus polysaccharide ameliorates H2O2-induced human umbilical vein endothelial cell injury.

Authors:  Ronghui Han; Futian Tang; Meili Lu; Chonghua Xu; Jin Hu; Meng Mei; Hongxin Wang
Journal:  Mol Med Rep       Date:  2017-04-26       Impact factor: 2.952

4.  Astragalus membranaceus Extract Attenuates Inflammation and Oxidative Stress in Intestinal Epithelial Cells via NF-κB Activation and Nrf2 Response.

Authors:  Simona Adesso; Rosario Russo; Andrea Quaroni; Giuseppina Autore; Stefania Marzocco
Journal:  Int J Mol Sci       Date:  2018-03-10       Impact factor: 5.923

5.  Adjuvant activity of Sargassum pallidum polysaccharides against combined Newcastle disease, infectious bronchitis and avian influenza inactivated vaccines.

Authors:  Li-Jie Li; Ming-Yi Li; Yan-Tuan Li; Jing-Jing Feng; Feng-Qiang Hao; Zhang Lun
Journal:  Mar Drugs       Date:  2012-12       Impact factor: 5.118

6.  Gingyo-san enhances immunity and potentiates infectious bursal disease vaccination.

Authors:  Che-Ming Hung; Chia-Chou Yeh; Kowit-Yu Chong; Hsiao-Ling Chen; Jiun-Yu Chen; Shung-Te Kao; Chih-Ching Yen; Ming-Hsien Yeh; Maw-Sun Lin; Chuan-Mu Chen
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-25       Impact factor: 2.629

7.  Effects of selenylation modification on immune-enhancing activity of garlic polysaccharide.

Authors:  Shulei Qiu; Jin Chen; Tao Qin; Yuanliang Hu; Deyun Wang; Qiang Fan; Cunshuai Zhang; Xingying Chen; Xiaolan Chen; Cui Liu; Zhenzhen Gao; Xiuping Li
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

8.  Flavone ingredients can synergistically inhibit NDV infecting cell and improve ND vaccine's protective rate.

Authors:  Zhang Yuqing; Sun Zhan'ao; Liu Jiaguo; Wang Deyun; Zhang Baokang; Yi Fang; Fan Yunpeng; Liu Dan; Liu Xu; Liu Cui; Hu Yuanliang
Journal:  Int J Biol Macromol       Date:  2012-05-07       Impact factor: 6.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.